Abatement of Cutaneous Kaposi's Sarcoma Associated with Cidofovir Treatment
Prevaccination Screening for Hepatitis B Among Sexually reported the abatement of Kaposi's Active Adolescents and Young Adults sarcoma (KS) in an AIDS patient who was being treated with cidofovir for cytomegalovirus (CMV) retinitis. The investigators SIR-We applaud the efforts by Alderman et al.
[1] to provide concluded that cidofovir, as well as other agents active against hepatitis B vaccination for adolescents and young adults in an herpesviruses, may have a therapeutic role in the treatment of KS.
inner-city clinic. Although hepatitis B vaccination has been recomIn fact, cidofovir and other antiherpetic agents (with the exception mended for adolescents and adults with risk factors for hepatitis of acyclovir) have been found to inhibit the replication of human B virus infection since the vaccine was licensed in 1981, the rate herpesvirus type 8 (HHV-8), the presumable etiologic agent of of vaccination coverage among most of these risk groups remains KS, in cell culture [2, 3] .
low. We agree with the investigators' conclusion that prevaccinaWe recently treated a patient without AIDS who had classic tion screening is not cost-effective among most populations of KS by intralesional injections of cidofovir [4] . After five weekly sexually active adolescents. However, prevaccination screening is injections of the drug, no clinical, histological, immunohistochemilikely to be even less cost-effective than calculated by the investical (persistence of Bcl-2 and p53 protein expression), or virological gators, because many participants younger than 19 years of age (persistence of HHV-8 DNA sequences) changes were noted. 
